1,2-dimethylhydrazine increases expression ISO RGD:1550408 6480464 1, 2-Dimethylhydrazine results in increased expression of EIF4G1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1550408 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EIF4G1 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1314591 6480464 everolimus inhibits the reaction [Estradiol results in increased phosphorylation of EIF4G1 protein] CTD PMID:16033851 17beta-estradiol increases phosphorylation ISO RGD:1314591 6480464 Estradiol results in increased phosphorylation of EIF4G1 protein CTD PMID:16033851 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550408 6480464 Tetrachlorodibenzodioxin affects the expression of EIF4G1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EIF4G1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EIF4G1 mRNA CTD PMID:32109520 , PMID:33387578 2-methylcholine affects expression ISO RGD:1314591 6480464 beta-methylcholine affects the expression of EIF4G1 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550408 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of EIF4G1 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1314591 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EIF4G1 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1314591 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EIF4G1 mRNA CTD PMID:28628672 , PMID:31601247 4-vinylcyclohexene dioxide affects expression ISO RGD:1550408 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of EIF4G1 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine increases expression ISO RGD:1314591 6480464 Decitabine results in increased expression of EIF4G1 mRNA CTD PMID:17908484 7-methyl-GTP affects binding ISO RGD:1314591 6480464 EIF4G1 protein binds to 7-methylguanosine triphosphate CTD PMID:25940091 7-methyl-GTP multiple interactions ISO RGD:1314591 6480464 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... CTD PMID:25940091 acrolein multiple interactions ISO RGD:1314591 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of EIF4G1 mRNA CTD PMID:32699268 aflatoxin B1 increases methylation ISO RGD:1314591 6480464 Aflatoxin B1 results in increased methylation of EIF4G1 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of EIF4G1 mRNA CTD PMID:33354967 aflatoxin B1 decreases methylation ISO RGD:1314591 6480464 Aflatoxin B1 results in decreased methylation of EIF4G1 exon CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:1550408 6480464 Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein], resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 all-trans-retinoic acid increases expression ISO RGD:1314591 6480464 Tretinoin results in increased expression of EIF4G1 mRNA CTD PMID:15894607 all-trans-retinoic acid multiple interactions ISO RGD:1314591 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of EIF4G1 mRNA CTD PMID:15894607 alpha-pinene multiple interactions ISO RGD:1314591 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of EIF4G1 mRNA CTD PMID:32699268 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of EIF4G1 mRNA CTD PMID:30779732 arsenite(3-) multiple interactions ISO RGD:1314591 6480464 arsenite promotes the reaction [EIF4E protein binds to EIF4G1 protein] more ... CTD PMID:12781867 , PMID:32406909 arsenous acid decreases expression ISO RGD:1314591 6480464 Arsenic Trioxide results in decreased expression of EIF4G1 mRNA CTD PMID:23911876 arsenous acid increases expression ISO RGD:1314591 6480464 Arsenic Trioxide results in increased expression of EIF4G1 mRNA CTD PMID:15894607 arsenous acid multiple interactions ISO RGD:1314591 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of EIF4G1 mRNA CTD PMID:15894607 benzo[a]pyrene increases mutagenesis ISO RGD:1314591 6480464 Benzo(a)pyrene results in increased mutagenesis of EIF4G1 gene CTD PMID:25435355 benzo[a]pyrene increases methylation ISO RGD:1314591 6480464 Benzo(a)pyrene results in increased methylation of EIF4G1 3' UTR CTD PMID:27901495 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:1314591 6480464 Mustard Gas results in increased phosphorylation of EIF4G1 protein CTD PMID:19845377 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter CTD PMID:23359474 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter CTD PMID:23359474 bisphenol A decreases expression ISO RGD:1314591 6480464 bisphenol A results in decreased expression of EIF4G1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1314591 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF4G1 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EIF4G1 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EIF4G1 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1314591 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G1 mRNA CTD PMID:28628672 bleomycin A5 increases expression ISO RGD:1314591 6480464 bleomycetin results in increased expression of EIF4G1 mRNA CTD PMID:21040473 cadmium dichloride increases expression ISO RGD:1314591 6480464 Cadmium Chloride results in increased expression of EIF4G1 mRNA CTD PMID:33129824 caffeine affects phosphorylation ISO RGD:1314591 6480464 Caffeine affects the phosphorylation of EIF4G1 protein CTD PMID:35688186 captan decreases expression ISO RGD:1550408 6480464 Captan results in decreased expression of EIF4G1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1314591 6480464 Carbamazepine affects the expression of EIF4G1 mRNA CTD PMID:24752500 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of EIF4G1 mRNA CTD PMID:23125180 chrysene increases expression ISO RGD:1550408 6480464 chrysene results in increased expression of EIF4G1 mRNA CTD PMID:26377693 cisplatin decreases expression ISO RGD:1314591 6480464 Cisplatin results in decreased expression of EIF4G1 mRNA CTD PMID:27594783 clofibrate decreases expression ISO RGD:1550408 6480464 Clofibrate results in decreased expression of EIF4G1 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1314591 6480464 cobaltous chloride results in decreased expression of EIF4G1 mRNA CTD PMID:19320972 coumarin affects phosphorylation ISO RGD:1314591 6480464 coumarin affects the phosphorylation of EIF4G1 protein CTD PMID:35688186 curcumin decreases phosphorylation ISO RGD:1314591 6480464 Curcumin results in decreased phosphorylation of EIF4G1 protein CTD PMID:18790744 cycloheximide multiple interactions EXP 6480464 Cycloheximide promotes the reaction [EIF4EBP1 protein binds to EIF4G1 protein] CTD PMID:22689575 D-glucose multiple interactions ISO RGD:1550408 6480464 Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein], resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of EIF4G1 mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression ISO RGD:1314591 6480464 decabromobiphenyl ether results in increased expression of EIF4G1 protein CTD PMID:31675489 deoxynivalenol increases phosphorylation ISO RGD:1550408 6480464 deoxynivalenol results in increased phosphorylation of EIF4G1 protein CTD PMID:23352502 dexamethasone multiple interactions ISO RGD:1314591 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EIF4G1 mRNA more ... CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1314591 6480464 Arsenic Trioxide results in increased expression of EIF4G1 mRNA CTD PMID:15894607 diarsenic trioxide decreases expression ISO RGD:1314591 6480464 Arsenic Trioxide results in decreased expression of EIF4G1 mRNA CTD PMID:23911876 diarsenic trioxide multiple interactions ISO RGD:1314591 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of EIF4G1 mRNA CTD PMID:15894607 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter CTD PMID:23359474 diclofenac affects expression ISO RGD:1314591 6480464 Diclofenac affects the expression of EIF4G1 mRNA CTD PMID:24752500 dicrotophos increases expression ISO RGD:1314591 6480464 dicrotophos results in increased expression of EIF4G1 mRNA CTD PMID:28302478 dioxygen increases expression ISO RGD:1550408 6480464 Oxygen deficiency results in increased expression of EIF4G1 mRNA CTD PMID:24205000 dioxygen affects methylation ISO RGD:1550408 6480464 Oxygen deficiency affects the methylation of EIF4G1 promoter CTD PMID:24205000 disodium selenite increases expression ISO RGD:1314591 6480464 Sodium Selenite results in increased expression of EIF4G1 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of EIF4G1 mRNA CTD PMID:25152437 doxorubicin decreases phosphorylation EXP 6480464 Doxorubicin results in decreased phosphorylation of EIF4G1 protein CTD PMID:19801490 doxorubicin decreases expression ISO RGD:1314591 6480464 Doxorubicin results in decreased expression of EIF4G1 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of EIF4G1 protein] CTD PMID:19801490 elemental selenium multiple interactions ISO RGD:1314591 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA CTD PMID:19244175 elemental selenium increases expression ISO RGD:1314591 6480464 Selenium results in increased expression of EIF4G1 mRNA CTD PMID:19244175 enzyme inhibitor multiple interactions ISO RGD:1314591 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF4G1 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:1550408 6480464 epoxiconazole results in decreased expression of EIF4G1 mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1550408 6480464 Ethanol affects the splicing of EIF4G1 mRNA CTD PMID:30319688 everolimus multiple interactions ISO RGD:1314591 6480464 Everolimus inhibits the reaction [Estradiol results in increased phosphorylation of EIF4G1 protein] CTD PMID:16033851 finasteride increases expression EXP 6480464 Finasteride results in increased expression of EIF4G1 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of EIF4G1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1550408 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EIF4G1 mRNA CTD PMID:22206623 folpet decreases expression ISO RGD:1550408 6480464 folpet results in decreased expression of EIF4G1 mRNA CTD PMID:31558096 fulvestrant multiple interactions ISO RGD:1314591 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene, [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene CTD PMID:31601247 genistein multiple interactions ISO RGD:1314591 6480464 ESR2 promotes the reaction [Genistein results in decreased expression of EIF4G1 protein] CTD PMID:20884965 genistein decreases expression ISO RGD:1314591 6480464 Genistein results in decreased expression of EIF4G1 protein CTD PMID:20884965 glafenine increases expression EXP 6480464 Glafenine results in increased expression of EIF4G1 mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:1550408 6480464 Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein], resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 hydrogen peroxide multiple interactions ISO RGD:1550408 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indometacin multiple interactions ISO RGD:1314591 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EIF4G1 mRNA more ... CTD PMID:28628672 ivermectin decreases expression ISO RGD:1314591 6480464 Ivermectin results in decreased expression of EIF4G1 protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:1314591 6480464 EIF4G1 protein affects the susceptibility to Josamycin CTD PMID:31915244 LY294002 multiple interactions ISO RGD:1314591 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] CTD PMID:12781867 lycopene increases expression ISO RGD:1314591 6480464 lycopene results in increased expression of EIF4G1 mRNA CTD PMID:16886892 mercury atom decreases expression ISO RGD:1550408 6480464 Mercury analog results in decreased expression of EIF4G1 mRNA CTD PMID:25056781 mercury(0) decreases expression ISO RGD:1550408 6480464 Mercury analog results in decreased expression of EIF4G1 mRNA CTD PMID:25056781 methyl methanesulfonate decreases expression ISO RGD:1314591 6480464 Methyl Methanesulfonate results in decreased expression of EIF4G1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1314591 6480464 methylmercuric chloride results in increased expression of EIF4G1 mRNA CTD PMID:23179753 , PMID:26272509 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of EIF4G1 mRNA CTD PMID:24136188 nickel sulfate increases expression ISO RGD:1314591 6480464 nickel sulfate results in increased expression of EIF4G1 mRNA CTD PMID:18651567 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of EIF4G1 mRNA CTD PMID:24136188 ozone multiple interactions ISO RGD:1314591 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:1314591 6480464 Acetaminophen results in decreased expression of EIF4G1 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of EIF4G1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1550408 6480464 Acetaminophen results in increased expression of EIF4G1 mRNA CTD PMID:17585979 paracetamol affects expression ISO RGD:1550408 6480464 Acetaminophen affects the expression of EIF4G1 mRNA CTD PMID:17562736 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of EIF4G1 mRNA CTD PMID:17616710 phenobarbital decreases expression ISO RGD:1550408 6480464 Phenobarbital results in decreased expression of EIF4G1 mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1314591 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] more ... CTD PMID:12781867 pyrogallol increases expression ISO RGD:1550408 6480464 Pyrogallol results in increased expression of EIF4G1 mRNA CTD PMID:20362636 resveratrol multiple interactions ISO RGD:1550408 6480464 resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 SB 203580 multiple interactions ISO RGD:1314591 6480464 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] CTD PMID:12781867 selenium atom multiple interactions ISO RGD:1314591 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA CTD PMID:19244175 selenium atom increases expression ISO RGD:1314591 6480464 Selenium results in increased expression of EIF4G1 mRNA CTD PMID:19244175 sirolimus multiple interactions ISO RGD:1314591 6480464 Sirolimus inhibits the reaction [EIF4G1 protein binds to 7-methylguanosine triphosphate] more ... CTD PMID:25940091 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of EIF4G1 mRNA CTD PMID:21297353 sodium arsenite multiple interactions ISO RGD:1314591 6480464 sodium arsenite results in decreased expression of and results in increased activity of EIF4G1 protein CTD PMID:30528433 sodium arsenite increases expression ISO RGD:1314591 6480464 sodium arsenite results in increased expression of EIF4G1 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of EIF4G1 mRNA CTD PMID:19281266 tebufenpyrad increases expression ISO RGD:1314591 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of EIF4G1 mRNA CTD PMID:33512557 testosterone enanthate affects expression ISO RGD:1314591 6480464 testosterone enanthate affects the expression of EIF4G1 mRNA CTD PMID:17440010 thimerosal decreases expression ISO RGD:1314591 6480464 Thimerosal results in decreased expression of EIF4G1 mRNA CTD PMID:27188386 titanium dioxide increases expression ISO RGD:1550408 6480464 titanium dioxide results in increased expression of EIF4G1 mRNA CTD PMID:29264374 torcetrapib increases expression ISO RGD:1314591 6480464 torcetrapib results in increased expression of EIF4G1 mRNA CTD PMID:23228038 torin 1 multiple interactions ISO RGD:1314591 6480464 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... CTD PMID:25940091 Tributyltin oxide decreases expression ISO RGD:1550408 6480464 bis(tri-n-butyltin)oxide results in decreased expression of EIF4G1 protein CTD PMID:19552622 Tributyltin oxide decreases phosphorylation ISO RGD:1550408 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of EIF4G1 protein CTD PMID:22174045 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of EIF4G1 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1550408 6480464 trimellitic anhydride results in increased expression of EIF4G1 mRNA CTD PMID:19042947 triptonide affects expression ISO RGD:1550408 6480464 triptonide affects the expression of EIF4G1 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1550408 6480464 Tungsten results in decreased expression of EIF4G1 mRNA CTD PMID:30912803 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of EIF4G1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1314591 6480464 Valproic Acid results in decreased methylation of EIF4G1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1314591 6480464 Valproic Acid affects the expression of EIF4G1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1314591 6480464 Valproic Acid results in increased expression of EIF4G1 mRNA CTD PMID:23179753 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of EIF4G1 mRNA CTD PMID:20566332 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of EIF4G1 mRNA CTD PMID:18042343 , PMID:23034163 vitamin E multiple interactions ISO RGD:1314591 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA CTD PMID:19244175 vitamin E increases expression ISO RGD:1314591 6480464 Vitamin E results in increased expression of EIF4G1 mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1314591 6480464 Vitamin E results in decreased expression of EIF4G1 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1314591 6480464 vorinostat results in decreased expression of EIF4G1 mRNA CTD PMID:27188386
